Cargando…
Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts
As patient derived xenograft (PDX) models are increasingly used for preclinical drug development, strategies to account for the nonhuman component of PDX RNA expression data are critical to its interpretation. A bioinformatics pipeline to separate donor tumor and mouse stroma transcriptome profiles...
Autores principales: | Liu, Yuanhang, Chanana, Pritha, Davila, Jaime I., Hou, Xiaonan, Zanfagnin, Valentina, McGehee, Cordelia D., Goode, Ellen L., Polley, Eric C., Haluska, Paul, Weroha, S. John, Wang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474864/ https://www.ncbi.nlm.nih.gov/pubmed/31004097 http://dx.doi.org/10.1038/s41598-019-42680-2 |
Ejemplares similares
-
Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts()()
por: Butler, Kristina A., et al.
Publicado: (2017) -
Frequent POLE-driven hypermutation in ovarian endometrioid cancer revealed by mutational signatures in RNA sequencing
por: Davila, Jaime I., et al.
Publicado: (2021) -
Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A
por: Torres, Diogo, et al.
Publicado: (2019) -
Conventional Chemotherapy and Oncogenic Pathway Targeting in Ovarian Carcinosarcoma Using a Patient-Derived Tumorgraft
por: Glaser, Gretchen, et al.
Publicado: (2015) -
Targeting HER2 in patient‐derived xenograft ovarian cancer models sensitizes tumors to chemotherapy
por: Harris, Faye R., et al.
Publicado: (2018)